Michael Severino, AbbVie president and soon-to-be Flagship Pioneering CEO-partner

April 13, 2022 10:43 AM EDT

AbbVie president Michael Severino heads to Flagship as biotech incubator's third CEO-partner in six days

Kyle LaHucik

Senior Reporter

AbbVie president and vice chair Michael Severino is leaving the Chicago-area pharma giant on May 31 to become a CEO-partner at prolific biotech creator Flagship …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AbbVie president Michael Severino heads to Flagship as biotech incubator's third CEO-partner in six days

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Ab­b­Vie pres­i­dent Michael Sev­eri­no heads to Flag­ship as biotech in­cu­ba­tor's third CEO-part­ner in six days

Senior Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

AbbVie president Michael Severino heads to Flagship as biotech incubator's third CEO-partner in six days